---
created: 2025-04-13
updated: 2025-04-13T10:51
id: "J+5jQ0#oIH"
specialty: cardio
specialty_id: 146
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::03-calcium-channel-blockers
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::09-cardiac
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::01-hypertension-treatment
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::02-calcium-channel-blockers
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::03-antihypertensives::01-calcium-channel-blockers
  - source/ak-step1-v11::
  - theme/uworld::1000-9999::1000-1999::1973
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::01-cardiology::pharm::cvs-pharm-1"
type: flashcard
---

# Question
Calcium channel blockers (CCBs) target voltage-gated **L**-type calcium channels

---

# Answer
"L type ca2+ channels are also known as the ""dihydropyridine receptor"""